Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
F. Zhou, S. Periasamy, N. Jackson…·A. Bukreyev
This study generates twelve SARS-CoV-2 viruses with mutations in individual proteins and shows that many have interferon-antagonizing activity and immunosuppressive effects in human cells and mice, with NSP1 and NSP15 having the greatest impact.
Y. Liu, X. Zhang, J. Liu…·P.-Y. Shi
This paper describes a live-attenuated SARS-CoV-2 vaccine candidate with deleted ORFs that shows reduced replication and attenuation in animal models, and reports its protective efficacy against wild-type virus challenge.
A. R. Shiakolas, N. Johnson, K. J. Kramer…·I. S. Georgiev
This study demonstrates that integrating ligand blocking into LIBRA-seq improves the efficiency of identifying potent SARS-CoV-2 neutralizing antibodies.
K. J. Kramer, N. V. Johnson, A. R. Shiakolas…·I. S. Georgiev
This study identifies a potent SARS-CoV-2 antibody, 54042-4, that neutralizes variants of concern and has a unique epitope and genetic structure.
D. C. Malherbe, D. Kurup, C. Wirblich…·A. Bukreyev
A single dose of the VSV-vectored vaccine ConVac expressing SARS-CoV-2 S1 subunit protects hamsters from weight loss and viral replication after SARS-CoV-2 challenge.
M. Meyer, Y. Wang, D. Edwards…·A. Bukreyev
This study evaluates mRNA-1273 vaccine efficacy in hamsters, showing reduced pulmonary immune activation and improved disease outcomes after prime-boost vaccination.